AdaptHealth Corp. (NASDAQ:AHCO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have been assigned an average rating of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $11.67.

Several research firms have recently commented on AHCO. Robert W. Baird decreased their price objective on AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research note on Wednesday, November 6th. Canaccord Genuity Group decreased their target price on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, November 6th. Royal Bank of Canada lowered their price target on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a report on Tuesday, November 19th. UBS Group reduced their price objective on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating for the company in a research note on Wednesday, November 6th. Finally, Truist Financial lowered their target price on shares of AdaptHealth from $13.00 to $12.00 and set a “buy” rating on the stock in a research note on Friday, November 15th.

Institutional Investors Weigh In On AdaptHealth

Several institutional investors and hedge funds have recently modified their holdings of the stock. FMR LLC boosted its position in shares of AdaptHealth by 9.3% during the third quarter. FMR LLC now owns 7,350,549 shares of the company’s stock worth $82,547,000 after acquiring an additional 624,645 shares during the last quarter. Reinhart Partners LLC. lifted its stake in AdaptHealth by 45.2% in the 3rd quarter. Reinhart Partners LLC. now owns 6,198,642 shares of the company’s stock worth $69,611,000 after purchasing an additional 1,929,339 shares in the last quarter. State Street Corp lifted its stake in AdaptHealth by 19.8% in the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock worth $46,316,000 after purchasing an additional 681,816 shares in the last quarter. Segall Bryant & Hamill LLC boosted its holdings in shares of AdaptHealth by 15.5% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 3,701,808 shares of the company’s stock valued at $41,571,000 after purchasing an additional 496,453 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in shares of AdaptHealth by 12.2% during the third quarter. Geode Capital Management LLC now owns 2,451,173 shares of the company’s stock valued at $27,532,000 after purchasing an additional 265,712 shares in the last quarter. Institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Down 1.8 %

AHCO opened at $9.36 on Thursday. The firm’s 50 day simple moving average is $10.04 and its two-hundred day simple moving average is $10.41. The company has a market capitalization of $1.26 billion, a PE ratio of -5.67, a PEG ratio of 1.36 and a beta of 1.10. AdaptHealth has a 1-year low of $6.46 and a 1-year high of $11.90. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34.

AdaptHealth (NASDAQ:AHCO) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.02). The company had revenue of $805.90 million during the quarter, compared to analysts’ expectations of $809.32 million. AdaptHealth had a positive return on equity of 9.62% and a negative net margin of 6.57%. The company’s revenue for the quarter was up .2% on a year-over-year basis. During the same quarter last year, the company earned $0.19 earnings per share. As a group, equities analysts forecast that AdaptHealth will post 0.88 EPS for the current year.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.